Multicenter prospective phase II study of sunitinib in non-clear cell type renal cell carcinoma

被引：0
|
作者：
Lee, J.
Ahn, J.
Lim, H.
Lee, S.
Kim, T.
Lee, D.
Cho, Y. M.
Hong, J.
Kim, C.
Ahn, H.
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[5] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea
[6] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[7] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.325
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
325
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma
    Lee, J. -L.
    Ahn, J. -H.
    Lim, H. Y.
    Park, S. H.
    Lee, S. H.
    Kim, T. M.
    Lee, D. -H.
    Cho, Y. M.
    Song, C.
    Hong, J. H.
    Kim, C. -S.
    Ahn, H.
    ANNALS OF ONCOLOGY, 2012, 23 (08) : 2108 - 2114
  • [2] Sunitinib in non-clear cell renal cell carcinoma (ncc-RCC): A phase II study
    Plimack, E. R.
    Jonasch, E.
    Bekele, B. N.
    Smith, L. A.
    Araujo, J. C.
    Tannir, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Molina, Ana M.
    Feldman, Darren R.
    Ginsberg, Michelle S.
    Kroog, Glenn
    Tickoo, Satish K.
    Jia, Xiaoyu
    Georges, Murielle
    Patil, Sujata
    Baum, Michael S.
    Reuter, Victor E.
    Motzer, Robert J.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 335 - 340
  • [4] Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Ana M. Molina
    Darren R. Feldman
    Michelle S. Ginsberg
    Glenn Kroog
    Satish K. Tickoo
    Xiaoyu Jia
    Murielle Georges
    Sujata Patil
    Michael S. Baum
    Victor E. Reuter
    Robert J. Motzer
    Investigational New Drugs, 2012, 30 : 335 - 340
  • [5] Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial
    Tannir, Nizar M.
    Jonasch, Eric
    Albiges, Laurence
    Altinmakas, Emre
    Ng, Chaan S.
    Matin, Surena F.
    Wang, Xuemei
    Wang, Xuemei
    Qiao, Wei
    Lim, Zita Dubauskas
    Tamboli, Pheroze
    Rao, Priya
    Sircar, Kanishka
    Karam, Jose A.
    McDermott, David F.
    Wood, Christopher G.
    Choueiri, Toni K.
    EUROPEAN UROLOGY, 2016, 69 (05) : 866 - 874
  • [6] A Phase 2 Trial of Sunitinib in Patients with Advanced Non-clear Cell Renal Cell Carcinoma
    Tannir, Nizar M.
    Plimack, Elizabeth
    Chaan Ng
    Tamboli, Pheroze
    Bekele, Nebiyou B.
    Xiao, Lianchun
    Smith, Lisa
    Lim, Zita
    Pagliaro, Lance
    Araujo, John
    Aparicio, Ana
    Matin, Surena
    Wood, Christopher G.
    Jonasch, Eric
    EUROPEAN UROLOGY, 2012, 62 (06) : 1013 - 1019
  • [7] EFFICACY AND SAFETY OF SUNITINIB IN PATIENTS WITH NON-CLEAR CELL RENAL CELL CARCINOMA
    Lee, J. -L.
    Ahn, J. -H.
    Park, S. H.
    Lim, H. Y.
    Lee, S. H.
    Kim, T. -M.
    Cho, Y. -M.
    Song, C.
    Hong, J. H.
    Kim, C. -S.
    Ahn, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 141 - 141
  • [8] Safety and efficacy of sunitinib for advanced non-clear cell renal cell carcinoma
    Shi, Hong-Zhe
    Tian, Jun
    Li, Chang-Ling
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (04) : 328 - 333
  • [9] Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (The ESPN Trial): A multicenter randomized phase 2 trial.
    Tannir, Nizar M.
    Jonasch, Eric
    Altinmakas, Emre
    Ng, Chaan S.
    Qiao, Wei
    Tamboli, Pheroze
    Rao, Priya
    McDermott, David F.
    Wood, Christopher G.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] ASPEN: A randomized phase II trial of everolimus versus sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Armstrong, Andrew J.
    Halabi, Susan
    Eisen, Tim
    Stadler, Walter Michael
    Jones, Robert R.
    Vaishampayan, Ultra N.
    Garcia, Jorge A.
    Hawkins, Robert E.
    Kollmannsberger, Christian K.
    Lusk, Christine
    Broderick, Samuel
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345